JP2019521137A5 - - Google Patents

Download PDF

Info

Publication number
JP2019521137A5
JP2019521137A5 JP2019501569A JP2019501569A JP2019521137A5 JP 2019521137 A5 JP2019521137 A5 JP 2019521137A5 JP 2019501569 A JP2019501569 A JP 2019501569A JP 2019501569 A JP2019501569 A JP 2019501569A JP 2019521137 A5 JP2019521137 A5 JP 2019521137A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
amino
oxadiazol
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019501569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019521137A (ja
JP7016344B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/067390 external-priority patent/WO2018011201A1/en
Publication of JP2019521137A publication Critical patent/JP2019521137A/ja
Publication of JP2019521137A5 publication Critical patent/JP2019521137A5/ja
Application granted granted Critical
Publication of JP7016344B2 publication Critical patent/JP7016344B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019501569A 2016-07-13 2017-07-11 レチノイド関連オーファン受容体γの新規芳香族複素環系モジュレーター Expired - Fee Related JP7016344B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16020268 2016-07-13
EP16020268.5 2016-07-13
PCT/EP2017/067390 WO2018011201A1 (en) 2016-07-13 2017-07-11 Heteroaromatic modulators of the retinoid-related orphan receptor gamma

Publications (3)

Publication Number Publication Date
JP2019521137A JP2019521137A (ja) 2019-07-25
JP2019521137A5 true JP2019521137A5 (cg-RX-API-DMAC7.html) 2020-07-30
JP7016344B2 JP7016344B2 (ja) 2022-02-04

Family

ID=56511303

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019501569A Expired - Fee Related JP7016344B2 (ja) 2016-07-13 2017-07-11 レチノイド関連オーファン受容体γの新規芳香族複素環系モジュレーター

Country Status (21)

Country Link
US (2) US10662181B2 (cg-RX-API-DMAC7.html)
EP (1) EP3484880B1 (cg-RX-API-DMAC7.html)
JP (1) JP7016344B2 (cg-RX-API-DMAC7.html)
KR (1) KR102490140B1 (cg-RX-API-DMAC7.html)
CN (1) CN109476653B (cg-RX-API-DMAC7.html)
AU (1) AU2017294969B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019000486A2 (cg-RX-API-DMAC7.html)
CA (1) CA3030370A1 (cg-RX-API-DMAC7.html)
DK (1) DK3484880T3 (cg-RX-API-DMAC7.html)
ES (1) ES2834009T3 (cg-RX-API-DMAC7.html)
IL (1) IL264141B (cg-RX-API-DMAC7.html)
MX (1) MX383770B (cg-RX-API-DMAC7.html)
MY (1) MY196990A (cg-RX-API-DMAC7.html)
PL (1) PL3484880T3 (cg-RX-API-DMAC7.html)
PT (1) PT3484880T (cg-RX-API-DMAC7.html)
RU (1) RU2771280C2 (cg-RX-API-DMAC7.html)
SA (1) SA519400868B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201811107WA (cg-RX-API-DMAC7.html)
UA (1) UA123330C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018011201A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201808436B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2771280C2 (ru) * 2016-07-13 2022-04-29 Лео Фарма А/С Гетероароматические модуляторы ретинол-связанного орфанного рецептора гамма
CN111825654A (zh) * 2019-04-19 2020-10-27 北京酷瓴生物技术有限公司 苯甲烯哌啶衍生物及其制备方法、中间体和用途
CN112898292A (zh) * 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型极光激酶抑制剂及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS244821B2 (en) * 1983-06-16 1986-08-14 Boehringer Ingelheim Ltd Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
WO2004073612A2 (en) 2003-02-13 2004-09-02 Merck & Co. Inc. Estrogen receptor modulators
FR2879381B1 (fr) 2004-12-15 2008-12-26 Thales Sa Systeme de distribution quantique de cle de cryptage a variables continues
MX2007012392A (es) * 2005-04-04 2007-12-05 Ab Science Derivados de oxazol sustituidos y su uso como inhibidores de tirosina cinasa.
EP2511275A1 (en) 2011-04-12 2012-10-17 Bioprojet Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
SI2928885T1 (sl) * 2012-12-06 2017-06-30 Glaxo Group Limited Modulatorji retinoidnemu sorodnega receptorja gama sirote (ror-gama) za uporabo pri zdravljenju avtoimunskih in vnetnih bolezni
WO2015067575A1 (en) * 2013-11-05 2015-05-14 F. Hoffmann-La Roche Ag 5,6,7,8-tetrahydro-5,8-methanocinnoline derivatives as rorc modulators for the treatment of autoimmune diseases
WO2015180613A1 (en) * 2014-05-28 2015-12-03 Glaxosmithkline Intellectual Property Development Limited Novel compounds
WO2015180612A1 (en) 2014-05-28 2015-12-03 Glaxosmithkline Intellectual Property Development Limited Novel compounds
ES2716966T3 (es) * 2014-05-28 2019-06-18 Glaxosmithkline Ip Dev Ltd Derivados de piperazina como moduladores de ROR-gamma
RU2771280C2 (ru) * 2016-07-13 2022-04-29 Лео Фарма А/С Гетероароматические модуляторы ретинол-связанного орфанного рецептора гамма

Similar Documents

Publication Publication Date Title
RU2014142598A (ru) Новые 4-метилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в
JP2019077725A5 (cg-RX-API-DMAC7.html)
JP2007523142A5 (cg-RX-API-DMAC7.html)
JP2010533158A5 (cg-RX-API-DMAC7.html)
JP2020516671A5 (cg-RX-API-DMAC7.html)
JP2019517455A5 (cg-RX-API-DMAC7.html)
JP2006506340A5 (cg-RX-API-DMAC7.html)
RU2018138707A (ru) Замещенные гетероарилом пиридины и способы применения
JP2006502134A5 (cg-RX-API-DMAC7.html)
JP2009534386A5 (cg-RX-API-DMAC7.html)
JP2006503081A5 (cg-RX-API-DMAC7.html)
JP2018535999A5 (cg-RX-API-DMAC7.html)
JP2017506237A5 (cg-RX-API-DMAC7.html)
JP2014525444A5 (cg-RX-API-DMAC7.html)
RU2015111133A (ru) Ингибиторы тирозинкиназы брутона
JP2008501673A5 (cg-RX-API-DMAC7.html)
RU2011105151A (ru) Азольные соединения
RU2015141360A (ru) Ингибиторы тирозинкиназы брутона
JP2015533157A5 (cg-RX-API-DMAC7.html)
JP2007528887A5 (cg-RX-API-DMAC7.html)
JP2015509510A5 (cg-RX-API-DMAC7.html)
JP2018016657A (ja) ヒトプロテインチロシンホスファターゼ阻害剤および使用法
JP2018502906A5 (cg-RX-API-DMAC7.html)
RU2015104962A (ru) Ди- и тригетероарильные производные в качестве ингибиторов агрегации белков
JP2018507234A5 (cg-RX-API-DMAC7.html)